Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02921269Phase 2Completed
Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+4 more
PrincipalinvestigatorStart date: 2017-03-10

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alessandro D Santin

NRG Oncology

Related
2 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score26%

Simon Lo

Fred Hutch/University of Washington Cancer Consortium

Related
1 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score17%

John K Chan

NRG Oncology

Related
3 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score17%

Jyoti S Mayadev

NRG Oncology

Related
3 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score17%

Ntokozo Ndlovu

Parirenyatwa Hospital

Related
1 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Allison E. Garda, MD

Mayo Clinic in Rochester

Related
1 trials

Shared therapeutic areas:

Cervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
Similarity Score13%

Charles A Leath

NRG Oncology

Related
1 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaStage IVA Cervical Cancer AJCC v6 and v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Michael Gold

NRG Oncology

Related
1 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Dennis Kuo

Montefiore Medical Center - Moses Campus

Related
1 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Sharon Manne

Rutgers Cancer Institute of New Jersey

Related
5 trials

Shared therapeutic areas:

Stage IV Cervical Cancer AJCC v6 and v7Stage IVA Cervical Cancer AJCC v6 and v7Stage IVB Cervical Cancer AJCC v6 and v7

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02921269Phase 2PrincipalInvestigator

Atezolizumab and Bevacizumab in Treating Patients With Recurrent, Persistent, or Metastatic Cervical Cancer

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+4 more
Completed

All 1 trials loaded